Patients receiving new kidneys and livers must take damaging anti-rejection drugs for the rest of their lives. Now researchers hope to train the immune system instead of just tamping it down.
The New York Times
By GINA KOLATA from NYT Health https://nyti.ms/2FEV6Wp
January 21, 2019 at 02:00PM
No comments:
Post a Comment